Medical News

RSS

New Interoperable Telesurgical software protocol

Using a new software protocol called the Interoperable Telesurgical Protocol, nine research teams from universities and research institutes around the world recently collaborated on the first successful demonstration of multiple biomedical robots operated from different locations in the U.S., Europe, and Asia. SRI International operated its M7 surgical robot for this demonstration.

18 Sep 2009

'Pathway to a Cure' walk event in California

Satellite Healthcare, one of the nation's first and leading providers of kidney dialysis services and a major sponsor of nephrology research, today announced their sponsorship of The Polycystic Kidney Disease Foundation's "Pathway to a Cure" walk event in California's capital of Sacramento.

18 Sep 2009

THHMHS finds place in Modern Healthcare's 100 Best Places to Work in Healthcare list

For the second straight year, Modern Healthcare magazine has named Texas Health Harris Methodist Hospital Southlake (THHMHS) one of the country's 100 Best Places to Work in Healthcare.

18 Sep 2009

Cowen Royalty appoints Strategic Advisory Board

Cowen Healthcare Royalty Partners ("Cowen Royalty") today announced that it has established a Strategic Advisory Board to extend the Firm's functional knowledge and geographic base within the healthcare industry.

18 Sep 2009

Raindance Technologies and CLC to develop software for resequencing analysis

RainDance Technologies and CLC bio today announced a partnership to develop specialized software for the analysis of targeted resequencing data generated by workflows incorporating RainDance’s Sequence Enrichment Solution and next generation DNA sequencing platforms.

18 Sep 2009

Interim trading update for third quarter of 2009 from Q-Med

In order to ensure that shareholders have up to date information, Q-Med (STO:QMED) has deemed it appropriate to provide an interim trading update for the third quarter of 2009. However, it should be noted that there remains a high degree of uncertainty given the current economic environment.

18 Sep 2009

Top official calls for quicker, improved response to military mental health needs

The Associated Press: "Adm. Mike Mullen, chairman of the Joint Chiefs of Staff, expressed frustration Wednesday with the pace of government work to heal the mental wounds of war. ... 'Shame on us if we don't figure it out this time around to make sure that doesn't happen,' Mullen said at a defense forum on the nonphysical injuries of war in Alexandria, Va., just outside of Washington.

18 Sep 2009

InSight's fourth quarter 2009 revenues decreases by 17.3% year-on-year

InSight Health Services Holdings Corp. (“InSight”) (OTCBB: ISGT) today announced its financial results for the fourth quarter and fiscal year ended June 30, 2009.

18 Sep 2009

Researchers to develop a safer and synthetic alternative to current heparin

With a $4.6 million grant from the National Institutes of Health (under the Bioengineering Research Partnership program), research led by Rensselaer Polytechnic Institute will make its important final steps toward the development of a safer, synthetic alternative to current heparin. The researchers believe that kilogram quantities of the new drug could be developed in under five years.

18 Sep 2009

Metabolic Research to participate in the Olympia Expo

Metabolic Research, Inc., makers of Stemulite, will have a booth in the Olympia Expo at the Las Vegas Convention Center South Hall, September 25th and 26th. The Stemulite booth will feature Corey and Paul Simpson, well-known super athlete trainers joined by Cristi Cuellar, Miss Bikini Mexico International Elite Champion.

18 Sep 2009

Nasdaq Stock Market issues deficiency letter to Neurobiological Technologies

Neurobiological Technologies, Inc. (Nasdaq: NTII) ("NTI") announced today that, on September 15, 2009, it received a letter from The Nasdaq Stock Market indicating that the bid price of NTI's common stock has closed below $1.00 per share for 30 consecutive business days.

18 Sep 2009

Study to determine the expression of S100A2 and p63 genes

As a member of the S100 family, S100A2 is considered a candidate tumor-suppressor gene. Recently, p63 gene, a new member of the p53 gene family, has been studied in the fields of tumorigenesis, cell apoptosis and tissue growth. At present, few studies have been carried out on the expression and relationship of S100A2 and p63 in EC.

18 Sep 2009

Pharmacyclics announces financial results for fourth quarter and FY 2009

Pharmacyclics, Inc. today reported financial results for its fourth quarter and fiscal year ended June 30, 2009. During the fourth quarter of fiscal 2009 Pharmacyclics incurred a GAAP net loss of $5.4 million, or $0.20 per share, compared to a net loss of $4.6 million, or $0.18 per share for the fourth quarter of fiscal 2008.

18 Sep 2009

Six former GRH patients to receive courage awards

The Glenrose Rehabilitation Hospital Foundation will present the fourth annual Courage Awards to six former Glenrose Rehabilitation Hospital (GRH) patients. The awards are presented to six people this year for the first time. As well, donors Louise and John Miller will be recognized for their many years of service and devotion to those treated for spinal cord injury at the GRH.

18 Sep 2009

VA warns veterans not to disclose personal information over telephone

The Department of Veterans Affairs (VA) is warning Veterans not to give credit card numbers over the phone to callers claiming to update VA prescription information.

18 Sep 2009

Researchers study the role of stem cells in development of liver cancer

Penn State College of Medicine researchers, in collaboration with colleagues at the University of Southern California, have taken an important step in understanding the role of stem cells in development of liver cancer.

18 Sep 2009

AstraZeneca US President Rich Fante accepts Freedom Award

AstraZeneca (NYSE: AZN) accepted the 2009 Secretary of Defense Employer Support Freedom Award on Thursday at a ceremony in Washington, D.C. This award is the highest recognition given by the U.S. government to employers for their outstanding support of employees who serve in the National Guard and Reserve.

18 Sep 2009

MemoryXL improves cognitive performance in Alzheimer's disease

Thomas Shea, Ph.D, and his team of scientists, tested the effects of MemoryXL previously shown to improve cognitive performance in Alzheimer's disease on adults without dementia.

18 Sep 2009

White House says Baucus' 'building block' is not the end of the debate

President Barack Obama's spokesman, Robert Gibbs, called the health care reform plan released Wednesday by Senate Finance Committee Chairman Max Baucus "an important building block" that "gets us closer to comprehensive health care reform" Roll Call reports.

18 Sep 2009

Results from the BLOSSOM trial announced by Arena Pharmaceuticals

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) reported today positive, highly significant top-line results from the BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity Management) trial.

18 Sep 2009